# A Study on the Prevention and Treatment of GIOP With Eldecalcitol

> **NCT06385093** · PHASE4 · UNKNOWN · sponsor: **Chinese SLE Treatment And Research Group** · enrollment: 314 (estimated)

## Conditions studied

- Rheumatoid Arthritis
- Osteoporosis
- Osteopenia

## Interventions

- **DRUG:** Eldecalcitol capsules
- **DRUG:** Alfacalcidol tablets
- **DRUG:** Calcium carbonate tablets

## Key facts

- **NCT ID:** NCT06385093
- **Lead sponsor:** Chinese SLE Treatment And Research Group
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-06
- **Primary completion:** 2025-12
- **Final completion:** 2026-03
- **Target enrollment:** 314 (ESTIMATED)
- **Last updated:** 2024-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06385093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06385093, "A Study on the Prevention and Treatment of GIOP With Eldecalcitol". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06385093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*